Impedance cardiography (ICG) developer CardioDynamics said it is getting closer to a sale of its wholly owned subsidiary Vermed, a manufacturer of medical electrodes and medical sensors for use in medical physiological measurement applications.
More than 50% of the necessary shareholder votes (approximately 27% of outstanding shares) needed to approve the Vermed sale have been cast, CardioDynamics said.The sale will allow San Diego, CA-based CardioDynamics to focus on its core technology, the company said. The decision will be finalized at the annual shareholders meeting on August 28, 2007.
By AuntMinnie.com staff writers
August 16, 2007
Related Reading
CardioDynamics outlines Nasdaq compliance options, August 9, 2007
CardioDynamics boosts sales force, December 12, 2006
CardioDynamics shows Q1 sales slump, April 7, 2006
CardioDynamics makes management moves, December 12, 2005
CardioDynamics posts Q2 downturn, June 29, 2005
Copyright © 2007 AuntMinnie.com
